None Eshwar Kumar Burra, None Kamran Shahid, None Yonas Tamene, None Shefali P. Mody, None Kaiser O. Sadiq, None Yogamba M. Shivakumar, None Pousette Farouk
{"title":"The Symphony of Survival: Sacubitril/Valsartan’s Heartfelt Impact on Mortality in Heart Failure: A Systemic Review","authors":"None Eshwar Kumar Burra, None Kamran Shahid, None Yonas Tamene, None Shefali P. Mody, None Kaiser O. Sadiq, None Yogamba M. Shivakumar, None Pousette Farouk","doi":"10.56570/jimgs.v2i2.122","DOIUrl":null,"url":null,"abstract":"Heart failure (HF) is a prevalent and debilitatingcondition affecting millions worldwide. Over the years,numerous therapeutic strategies have been employedto manage HF, improving patients' quality of life, andreducing morbidity and mortality rates.Sacubitril/valsartan, a novel combination drug, hasemerged as a promising therapeutic option in themanagement of HF with reduced ejection fraction(HFrEF This abstract provides a comprehensive reviewof the use of sacubitril/valsartan in treating HF patients.","PeriodicalId":315163,"journal":{"name":"Journal For International Medical Graduates","volume":"27 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal For International Medical Graduates","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56570/jimgs.v2i2.122","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Heart failure (HF) is a prevalent and debilitatingcondition affecting millions worldwide. Over the years,numerous therapeutic strategies have been employedto manage HF, improving patients' quality of life, andreducing morbidity and mortality rates.Sacubitril/valsartan, a novel combination drug, hasemerged as a promising therapeutic option in themanagement of HF with reduced ejection fraction(HFrEF This abstract provides a comprehensive reviewof the use of sacubitril/valsartan in treating HF patients.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
